Olaparib promotes FABP4 expression and reduces antitumor effect in ovarian cancer cells with a BRCA1 mutation

ABSTRACT:

SUBMITTER: Huang W 

PROVIDER: S-EPMC11605280 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature